March 10, 2025
March 7, 2025 — The FDA has approved a new gene therapy for macular telangiectasia type 2 (MacTel), a rare eye disease that causes vision loss. The […]
March 6, 2025
A gospel truth in ophthalmology has been that people of African ancestry are more likely to develop glaucoma, but a new study clouded the picture. The […]
February 28, 2025
Glaucoma is one of the three leading causes of blindness in Germany and worldwide. This neurodegenerative disease progressively damages the retinal nerve fibres, leading to irreversible […]
February 26, 2025
Community health centers are well positioned to expand vision care services such as vision testing and screening for glaucoma and retina disease to people who have […]
February 25, 2025
TOPLINE: In patients without diabetes diagnosed with overweight or obesity, the use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) led to a greater reduction in […]
February 18, 2025
The shortage of physicians in the United States isn’t a new phenomenon. Unfortunately, it is also one that isn’t expected to disappear anytime soon. “I would […]
February 7, 2025
TOPLINE: At least nine patients using the glucagon-like peptide 1 (GLP-1) receptor agonists semaglutide and tirzepatide developed ophthalmic complications, of whom seven had nonarteritic anterior ischemic […]
February 6, 2025
TOPLINE: Oral use of guanfacine by children and adolescents newly diagnosed with attention-deficit/hyperactivity disorder (ADHD) increases corneal aberrations but does not affect other ocular parameters. METHODOLOGY: […]
February 5, 2025
TOPLINE: Strabismus surgery resolves diplopia or double vision in three fourths of senior patients aged > 80 years after the initial procedure, with the resolution rate […]